Search

Start typing to see results...

Today Market

Stock Performance

Today Market

Today's High

84,037.96

Todday's Low

82,403.27

Open at

82,558.25

Previous Close

83,021.75

Volumes

0.00

Avg Price

897.96

Historical Performance

News

30 Oct 26
AstraZeneca India to review financial results at board meeting on November 5, 2026
AstraZeneca Pharma India Limited will hold a meeting of its Board of Directors on Thursday, November 5, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, the company said in a filing.
27 Oct 26
AstraZeneca India confirms compliance with SEBI regulations for the quarter ending September 30, 2026
AstraZeneca Pharma India Limited informed the BSE Limited and National Stock Exchange of India Ltd.
16 Oct 26
AstraZeneca India discloses ESG rating of 73 from NSE Sustainability Ratings and Analytics
Astrazeneca Pharma India Ltd announced on October 16, 2026, a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding an Environmental, Social and Governance (“ESG”) rating assigned by NSE Sustainability Ratings and Analytics Limited, which is 73 for the financial year 2025-26; the company notes it did not engage NSE Sustainability Ratings and Analytics Limited, and the rating was independently prepared based on publicly available information, with no enhancements, assignments, or withdrawals related to any instruments.
18 Sep 26
AstraZeneca Pharma India Limited faces Rs 1.88 lakh penalty for filing delays related to a managing director appointment
AstraZeneca Pharma India Limited has disclosed receiving an order from the Registrar of Companies, Bengaluru, dated September 17, 2026, imposing a penalty of Rs 1,88,000 on the company and Rs 50,000 each on its erstwhile officers, related to a delay in filing Form MR-2 concerning the appointment of Dr.

Historical Prices

Share Price Chart

Historical Share Price

Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
19-11-26 6023.50 6148.50 5994.50 6113.00 11322 2126 69017781.00 25514.30
18-11-26 6170.00 6400.00 5981.50 6043.50 28729 6276 178100731.50 25227.95
17-11-26 6033.00 6212.50 5950.00 6168.00 17433 5020 106359492.50 25387.40
16-11-26 6031.50 6075.00 5900.50 6033.00 34487 6606 207502158.50 25291.10
13-11-26 6438.50 6438.50 5998.50 6031.50 33306 5386 204481528.50 25144.30
12-11-26 6592.50 6592.50 6410.00 6438.50 3361 1368 21771100.00 25299.35
11-11-26 6514.50 6615.00 6462.00 6507.00 11968 2184 78468006.00 25255.05
09-11-26 6484.00 6530.00 6401.00 6514.50 10012 2126 64753518.00 25044.65
08-11-26 6507.50 6583.00 6435.50 6479.50 2544 777 16570013.00 24986.40
06-11-26 6294.00 6801.00 6294.00 6373.50 62230 17438 408169745.00 25030.35

Fundamentals

Company Valuation

Market Cap (₹cr)

15301.13

PE Ratio

81.29

PB Ratio

17.41

Dividend Yield

0.59

ROE

22.82

ROCE

27.86

Book Value (₹)

351.568

Face Value (₹)

2

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 18750000 75.00 18750000 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 18750000 75.00 18750000 1
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group 18750000 75.00 18750000 1
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 375 0.00 250 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 660341 2.64 660341 93
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1751929 7.01 1751929 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 20677 0.08 20677 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2433322 9.73 2433197 109
plus  Non Institution
Bodies Corporate 261446 1.05 261446 258
Clearing Members 117 0.00 117 2
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 89781 0.36 89281 1078
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 85002 0.34 85001 755
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1279601 5.12 1279601 3
Individuals holding nominal share capital up to Rs. 1 lakh 1925521 7.70 1818478 28159
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 127 0.00 127 3
Others 90772 0.36 90772 1
Sub Total 3816678 15.27 3709134 30298
Total Public Shareholding 6250000 25.00 6142331 30407
Total of Promoter & Public ShareHolding 25000000 100.00 24892331 30408
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 25000000 100.00 24892331 30408

Financials (₹ in cr)

No Data Available

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 5.005.005.005.005.005.00
Reserves Total 867.79765.35706.92583.69506.39451.17
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds872.79770.35711.92588.69511.39456.17
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 110.6635.734.597.218.6312.14
Total Debt110.6635.734.597.218.6312.14
Other Liabilities37.7515.326.218.567.506.41
Total Liabilities1021.20821.40722.72604.46527.52474.72
APPLICATION OF FUNDS :
Gross Block 184.76217.62187.13179.12168.83159.78
Less : Accumulated Depreciation 67.29153.38120.45110.2694.3478.82
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 117.4764.2466.6868.8674.4980.96
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress0.000.000.271.332.204.02
Producing Properties0.000.000.000.000.000.00
Investments 0.000.000.000.000.000.00
Current Assets, Loans & Advances
Inventories 1027.33548.50227.88190.21140.22159.80
Sundry Debtors 213.68184.88153.13107.5285.8985.19
Cash and Bank Balance448.62536.70505.84500.48448.46352.35
Loans and Advances 50.3072.2745.8637.2631.1021.42
Total Current Assets1739.931342.35932.71835.47705.67618.76
Less : Current Liabilities and Provisions
Current Liabilities 906.57579.55305.23336.31281.06257.44
Provisions 61.33117.1750.0844.1047.9842.55
Total Current Liabilities & Provisions967.90696.72355.31380.41329.04299.99
Net Current Assets772.03645.63577.40455.06376.63318.77
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets65.2750.5422.3122.2018.1717.31
Deferred Tax Liability27.478.981.061.531.872.78
Net Deferred Tax37.8041.5621.2520.6716.3014.53
Other Assets93.9069.9757.1258.5457.9056.44
Total Assets1021.20821.40722.72604.46527.52474.72
Contingent Liabilities121.2398.41137.64131.62121.3785.66

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -9.46-24.48-44.38-65.59-91.97
Investing Activities 4.7418.1121.7430.8018.69
Net Cash Flow 96.0851.925.2330.57-88.42
Operating Activities 100.8058.2927.8765.36-15.14

Peers

Abbott India Ltd

26,525.00

(+3.23%)
Evonile Pharma L...

1,367.60

(-1.82%)
Glaxosmithkline ...

2,727.60

(+0.52%)
Pfizer Ltd

3,856.00

(+0.15%)
Procter & Gamble...

5,589.50

(+0.96%)
Sanofi Consumer ...

3,442.40

(-1.49%)
Sanofi India Ltd

3,206.10

(+0.11%)

Corporate Actions

DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
SDN
Shilpa Divekar Nirula
Chairman & Independent Directo
Executive
Functional Directors
PRA
Praveen Rao Akkinepally
Managing Director / Business Unit Head
MD
BA
Bhavana Agrawal
Executive Director / Whole Time Director / CFO
Exec.
HBC
Hooi Bien Chuah
Non Executive Director
Exec.
Independent Directors
RA
Revathy Ashok
Independent Non Exe. Director
Ind.
MW
MONICA WIDHANI
Independent Non Exe. Director
Ind.
Other Officials
TS
Tanya Sanish
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Astrazeneca Pharma India Ltd? −

Astrazeneca Pharma India Ltd trades on NSE under ASTRAZEN and on BSE under code 506820. The ISIN is INE203A01020 and the face value is Rs 2.

What is the share price of Astrazeneca Pharma India Ltd today? +

As of 20 November 2026, Astrazeneca Pharma India Ltd trades at Rs 6,167.50, a change of 54.50 (0.89%) on the day. Prices are live and subject to change.

What is the market capitalisation of Astrazeneca Pharma India Ltd? +

As of 20 November 2026, Astrazeneca Pharma India Ltd has a market cap of about Rs 15301.13 crore. This figure is live and moves with the share price.

Is Astrazeneca Pharma India Ltd profitable? +

In , Astrazeneca Pharma India Ltd reported a profit after tax of Rs crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Astrazeneca Pharma India Ltd? +

: As of 20 November 2026, the PE (TTM) for Astrazeneca Pharma India Ltd is 81.29 and the price-to-book ratio is 17.41. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Astrazeneca Pharma India Ltd pay a dividend? +

As of 20 November 2026, the dividend yield for Astrazeneca Pharma India Ltd is 0.59%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Astrazeneca Pharma India Ltd? +

As of the latest disclosed pattern, promoters hold 75.00% of Astrazeneca Pharma India Ltd. Public shareholding is 25.00%, including mutual funds at 7.01% and foreign institutional investors at 2.64%.

What were the latest annual financials of Astrazeneca Pharma India Ltd? +

In , Astrazeneca Pharma India Ltd reported net sales of Rs crore, revenue growth of %, and earnings per share of Rs .